ADHD & Psychopharmacology

ADHD & Psychopharmacology




Psychoactive drugs target specific receptors in the nervous system to effect extensive changes in the psychological roles. The interaction between psychoactive drugs and the target receptors is known as drug action. The resultant change in psychological or physiological function is known as drug effect (Adler, Reingold, Morrill, & Wilen, 2006). Psychopharmacology entails an extensive research in a general range of drug classes including stimulants and antidepressants. These drugs modify or alter one or more roles of synaptic transmission. Neurotransmitters provide the medium by which neurons communicate. consequently, psychoactive drugs affect the brain by modifying this communication. The effects of these drugs vary from: [ 1] acting as a precursor for the neurotransmitter; [ 2] restraining neurotransmitter combination; [ 3] barring postsynaptic receptors among others (Adler et al., 2006).

Psychoactive drugs also use hormones to affect communications between cells. Hormones are known to travel meaningful distances before reaching their target body cells. consequently, the endocrine system is another target of the psychoactive drugs. The psychoactive drugs can: [ 1] change secretion of many hormones; [2] modify the behavioral responses to drugs. Some of the hormones in the body are known to have psychoactive effect by themselves (Adler et al., 2006)

Psychopharmacological substances

The opiate drugs have been identified as one of the psychopharmacological substances. The opiates form a class of narcotic analgesics. They are mainly use to help patients conquer pain without causing unconsciousness. However, they do not rule relaxation and sleep. It has also been noted that overdose of this drug can consequence to death. The ability of this drug to reduce pain relies on a complicate set of neuronal pathways at various points along the spinal cord. Opiate drugs reduce transmission of pain alerts to the brain (Bouffard, Hechtman, Minde, & laboni-Kassab, 2003).

The other kind of Psychopharmacological substances is hypnotics. Hypnotics are mainly used to treat sleep disorders. Studies indicate that hypnotics are greatly preferred to other sedatives because they are less addictive. The third kind of psychopharmacological substances is hallucinogens. Hallucinogens rule to synesthesia sensations, making the user imagine things that do not exist. The other kind is the Benzodiazepines commonly used to decline anxiety symptoms, insomnia or already manage alcohol withdrawal alcohol symptoms (Banaschewski, Roessner, Dittmann, Santosh, & Rothenberger, 2004).

Antidepressants decline symptoms of mood swings. The shared types of antidepressant drugs are the Monoamine oxidase inhibitors (MAOIs), Tricyclic antidepressants and Selective serotonin reuptake inhibitors (SSRIs).One of the most important factor to consider while choosing an antidepressant is there side effects. The antipsychotic substances are divided into first generation and second generation. The antidepressants are known to affect movement of the user (Adler et al., 2006).

On stimulants, cocaine is one of the most known stimulants. Cocaine is known to cause increased alertness, heightened confidence, decreased fatigue and a general sense of well being. There are also several side effects which are associated with the abuse of cocaine. It has been found out that abuse of cocaine leads to anxiety, total insomnia, irritability, psychotic symptomatology (Banaschewski et al., 2003). Another shared kind of stimulant is known as Amphetamines. Numerous forms of this stimulant are used to manage the symptoms of attention deficit hyperactivity disorder [ADHD] (Banaschewski et al., 2003).

Attention-deficit hyperactivity disorder (ADHD)

Attention-deficit hyperactivity disorder (ADHD) is a disorder that commonly affects children and can persist into adulthood for some. Children experiencing from ADHD have difficulties paying attention. They are unable to follow simple instructions and are quickly bored or devastated by responsibilities. They also seemed not to relax and they act at the stimulus of the moment. They rarely do stop to think before engaging into action. This can be argued that it is a shared behavior with all the children; however, it is noticeable in children experiencing from ADHD. Studies indicate that children experiencing from ADHD perform poorly in school (Handen, Taylor, & Tumuluru, 2011).

However, it is important to observe that ADHD not only affects children, but also adults. Its symptoms in adults include problems with time management, poor organization skills, and employment problems among others (Asherson, Chen, Craddock, & Taylor, 2007). Other symptoms include poor anger management, relationship problems due to low self-esteem among others.

The precise cause of ADHD has not been identified, although there is current research on the human brain to establish the cause. Some of the factors that are connected with this disease include:

[1] Heredity; ADHD has been observed to run in families. This implies that children have a high probability of inheriting ADHD from their parents;

[2] chemical imbalance of brain chemicals whereby researchers argue that imbalance of brain chemicals especially the ones that are responsible for the transmission of nerve impulses may be a contributing factor in the development of ADHD symptoms; and

[3] Changes in the area of the brain especially areas which control attention may also be another contributing factor (Bouffard et al., 2003).

Psychopharmacological Treatment of ADHD

ADHD is a disorder that can consequence in several secondary problems. Psychopharmacological treatments are necessary in the treatment of ADHD. Stimulant treatment has for many years been confirmed to be effective and safe. One of the first stimulants to be used to manage ADHD is Amphetamine. Recent studies indicate that the soundness of ADHD diagnosis is now recognized despite the fact that its prevalence and the level of consistent symptoms in addition as the identification of symptoms in adults keep disputed (Asherson et al., 2007).

The probabilities of a decline in symptoms and problems over time in persons experiencing from ADHD have been an issue of concern. The meaningful issues in this argue are the dissimilarities between syndromatic against symptomatic persistence. It is also important to consider the fact there is a strong similarity between the symptoms of ADHD and other psychiatric disorders. High similarity complicates diagnosis of ADHD. Recent studies indicate that ADHD is shared among inmates, and teens.

Stimulant medication

Psychostimulant drugs have been for many years used for ADHD treatment. Many heatlh care personnel attending to patients experiencing from ADHD have observed impressive outcomes in the use of Psychostimulant drugs. Studies indicate high levels of efficacy with the use of stimulant drugs such as methylphenidate in the treatment of ADHD (Asherson et al., 2007; Bouffant et al., 2003). Additionally, other psychiatric symptoms associated with other psychiatric conditions such as depression and anxiety improved with the use of methylphenidate. This method that methylphenidate is effective and well tolerated in ADHD treatment. Because of their effectiveness and less side effects, stimulants are often considered as first-line treatment for ADHD symptoms (Banaschewski et al., 2003).

The precise mechanism of action of stimulants remains largely unknown. However, stimulants are thought to hinder reuptake of norepinephrine and dopamine presynaptically. Recent research indicates that about 20 %-50% of adults being treated of ADHD do not respond to the stimulants due to inadequate symptom reduction or without of ability to tolerate negative effects (Handen et al., 2011). For adults who respond to Psychostimulant treatment, a reduction of about 50 % of ADHD symptoms is observed. For the ADHD patients who are unable to tolerate stimulants, non-stimulants such as Atomoxetine can be used (Banaschewski et al., 2004).

past studies have indicated a vigorous efficacy of stimulants on managing the chief symptoms of ADHD in adults (Banaschewski et al., 2004). Some of the researchers have carried an extensive research on measure-response correlation in ADHD treatment (Bouffard et al., 2003). Additionally, Banaschewski et al., (2004) observe that the several randomized controlled trials on ADHD establish the efficacy and safety of stimulants in ADHD treatment. additionally, past studies indicate a reliable evidence for the efficiency of methylphenidate and amphetamines on minimizing ADHD symptoms (Asheron et al. 2007). These stimulants have proven to be effective especially during the first weeks of treatment, and they have minimal negative effects (Bouffard et al., 2003; Asherson et al., 2007; Banaschewski et al., 2004).

however, Adler et al., (2006) observe that the efficiency of methylphenidate in the treatment of the chief symptoms of ADHD was connected with physician’s use of higher doses and exaggerated rating of outcomes. As mentioned earlier, the use of physician’s rating may overestimate the efficacy of this stimulant. Recent studies indicate that the earlier hypothesized measure-response correlation in stimulant treatment, in sustain of high doses, is not so apparent. The measure-response correlation seems to be extremely different among patients, implying that the measure must all the time be individualized for average efficiency and tolerability (Asherson et al., 2007; Adler et al., 2006).

Some of the studies conducted on the efficacy of methylphenidate maintained an open long-term follow up and established that very few patients adhered to medication at the period of follow-up (Handen et al., 2011). Another recent research from Canada pointed out that adherence by the 7th month after the first prescription was as low as 23.5 % for methylphenidate (Handen et al., 2011). Another study conducted by Norwegian Health authorities on ADHD patients treated using stimulant drugs indicated that nearly 80 % of patients do not to pay attention to the initial prescription. It is consequently apparent that most ADHD adult patients choose not to to pay attention to initial prescription despite the positive response on chief ADHD symptoms (Handen et al., 2011).

A cross section review of most studies point out that very few patients adhered to medication at the time of the follow-up (Handen et al., 2011). This issue makes it difficult to establish the effect of comorbidity on reaction to treatment in adult ADHD. When assessing efficiency of medication on outcome parameter for other symptoms except chief ADHD symptoms i.e. quality of life, it becomes difficult to find a positive effect. In fact, there are possibilities for a negative effect on outcome parameters of anxiety and depression. One reason that can be given behind this consequence may be many studies have low baseline parameters on measuring scales like anxiety and depression. Another possible explanation is that a meaningful number of patients do not experience a break in symptoms of depression from their ADHD treatment. The persistent depression may consequence to a negative attitude on treatment adherence (Banaschewski et al., 2004).

However, it is worth to concede that stimulant drugs are often helpful in treating ADHD. It considerably improves the patient’s attention and ability to learn. These drugs are also known to curb the coordination problem, which affects sports and handwriting. Under the prescription, these drugs do not make the user feel high although it is normal for them to feel different. As stated earlier, there is no persuading evidence that ADHD patients risk becoming addicted to the Psychostimulant drugs used to treat ADHD. In sustain of this argument, a study conducted by Harvard Medical school found that the rate of substance abuse were lower among the patients of ADHD who adhered to medication (Adler et al., 2006).

It is important to observe that not all drugs used to treat ADHD are stimulants. There are newer kinds of drugs that are non-stimulants. These drugs proportion similar outcomes with stimulants only that they function in a different way. Another important category of drugs used to treat ADHD are antidepressants, which mainly act on the brain chemicals. They can be used alone, or combined with the stimulants (Adler et al., 2006).

Clinical effects of Stimulants

Stimulants have proved a high behavioral efficiency in several randomized regulated trials. It has been observed that stimulants efficiently alleviate some of the symptoms of ADHD such as restlessness, poor attention span, and hyperactivity among others. Stimulants enhance reaction time, vigilance, short-term memory among others. However, stimulant medications are connected with few side effects (Bouffard et al., 2003).

Side Effects of ADHD drugs

Most of the side effects that have been related with the treatment of ADHD are minor. consequently, they should not contribute to stopping the treatment. Some of these side effects include: [1] Decreased appetite whereby patients suffer loss of appetite especially during the day and regain it by suppertime. Good nutrition should be a top priority for patients experiencing from ADHD; [2] Insomnia; however this can be regulated by taking the medication earlier in the morning; [3]This treatment also increases blood pressure and pulse. This increase in blood pressure has major clinical significance for patients experiencing from cardiac diseases (Gualtieri, Ondrusek, & Finley, 1985). ADHD medications only manage ADHD symptoms the day they are taken. Patients should consequently observe that the disorder is not cured, and that it is important to to pay attention to medication (Banaschewski et al., 2004).

Conclusion

In treating ADHD, it is advisable to make follow-ups on the patient and take measures to stop discontinuation from the medication. Clinicians should observe that the treatment of ADHD does not clearly relieve the patients from symptoms. It is also important for clinicians to establish an accurate diagnosis, sustain of the patient, use correct dosage, and observe the efficiency of the drug. additionally, there is the need for clinicians to have the right knowledge concerning ADHD including the merits, demerits, and the mechanism of action of the drug they use for treating ADHD. It is also the clinicians’ responsibility to make a follow up on their patients to ensure that they to pay attention to the medications prescribed to them. As mentioned earlier, non-stimulant drugs have also proved to be successful. In conclusion, there is sound evidence for both pharmacological and psychotherapeutic treatment of ADHD in adults. The clinicians are also advised to make use of combined medication approach as an efficient way of overcoming numerous comorbid conditions such as depression, bipolar conditions among others while at the same time treating ADHD.

References

Adler, L.A., Reingold, L. S., Morrill, M. S., & Wilens T. E. (2006). Combination pharmacotherapy for adult ADHD.Current Psychiatry Report, 8, 409-415.

Asherson, P., Chen, W., & Craddock, B., Taylor, E. (2007). Adult attention-deficit hyperactivity disorder: Recognition and treatment in general adult psychiatry. The British Journal of Psychiatry, 190, 4-5.

Banaschewski, T., Roessner, V., Dittmann, R. W., Santosh, P. J., & Rothenberger, A. (2004). Non-stimulant medications in the treatment of ADHD. European Child & Adolescent Psychiatry, 13, 102-116.

Bouffard, R., Hechtman, L., Minde, K., & laboni-Kassab, F. (2003). The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Canadian Journal Psychiatry, 48, 546-554.

Gualtieri, C. T., Ondrusek, M. G., & Finley, C. (1985). Attention deficit disorders in adults. Clinical Neuropharmacology, 8, 343-356.

Handen, B. L., Taylor, J., & Tumuluru, R. (2011). Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder. International Journal of Adolescent Medicine and Health, 23, 3, 167-173.




leave your comment

Search

Top